Oxford-AstraZeneca vaccine 95% effective in controlling ’Delta’ variants: NRC Chairman
The Oxford-AstraZeneca COVISHIELD vaccine was 95% effective in controlling the ’Delta’ variants which have been identified in the country, the National Research Council (NRC) Chairman Prof. Hemantha Dodampahala said.
Sri Lanka’s health experts, today raised serious concerns over the new variant of the COVID-19 which had been detected in South Africa and said Sri Lanka’s borders had gone on alert.
Comments
Post a Comment